Quarterly Report · 10-Q
IRIDEX Corporation
IRIXNASDAQEQUITYCurrent
Quarterly Report
Company context
Iridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, which include capital equipment and consumable probes for the ophthalmology market. The Company’s proprietary MicroPulse® technology delivers the therapeutic benefits of laser treatment while minimizing tissue damage, offering a safe, effective, and proven treatment for targeted sight-threatening eye conditions. Iridex’s current product line is used for the
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗